Aging-related decrease in liver peroxisomal fatty acid oxidation in control and clofibrate-treated mice. A biochemical study and mechanistic approach

Mechanisms of Ageing and Development

Volumn 87, Issue 2, 1996, Pages 115-126

  Perichon R ^a   Bourre, J M ^a  

^a HÔPITAL FERNAND WIDAL   (France)

Author keywords

Aging; Catalase; Cytochrome P450; Liver; Mouse; Peroxisome; Urate oxidase; Very long chain fatty acid; oxidation

Indexed keywords

ACYL COENZYME A OXIDASE; ARACHIDONIC ACID; CATALASE; CLOFIBRATE; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; URATE OXIDASE; VERY LONG CHAIN FATTY ACID;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; FEMALE; LIPID COMPOSITION; LIVER MICROSOME; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL;

EID: 18344418461     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/0047-6374(96)01705-8     Document Type: Article

References (42)

1. R.R. Brenner, Effect of unsaturated fatty acids on membrane structure and enzyme kinetics. Prog. Lipid Res., 23 (1984) 69-96.
2. C.D. Stubbs and A.D. Smith, The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. Biochim. Biophys. Acta, 779 (1984) 89-137.
3. J.M. Bourre, G. Pascal, G. Durand, M. Masson, O. Dumont and M. Piciotti, Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes and oligodendrocytes) and subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J. Neurochem., 43 (1984) 342-348.
4. C.T. Holloway and P.B. Holloway, Stearyl-CoA desaturase activity in mouse liver microsomes of varying lipid composition. Arch. Biochem. Biophys., 167 (1975) 496-504.
5. G.P. Mannaerts, L.J. Debeer, J. Thomas and P.J. De Schepper, Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates and isolated hepatocytes from control and clofibrate-treated rats. J. Biol. Chem., 254 (1979) 4585-4595.
6. J. Kondrup and P.B. Lazarow, Flux of palmitate through the peroxisomal and mitochondrial β-oxidation systems in isolated rat hepatocytes. Biochim. Biophys. Acta, 835 (1985) 147-153.
7. I. Singh, H.W. Moser, A.B. Moser and Y. Kishimoto, Adrenoleukodystrophy: impaired oxidation of long chain fatty acids in cultured skin fibroblasts and adrenal cortex. Biochem. Biophys. Res. Commun., 102 (1981) 1123-1229.
8. B.S. Jakobs and R.J.A. Wanders, Conclusive evidence that very long chain fatty acids are oxidized exclusively in peroxisomes in human skin fibroblasts. Biochem. Biophys. Res. Commun., 178 (1991) 842-847.
9. P.B. Lazarow and C. de Duve, A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidaemic drug. Proc. Natl. Acad. Sci. USA, 73 (1976) 2043-2046.
10. I. Zs-Nagy, The role of membrane structure and function in cellular aging: a review. Mech. Ageing Dev., 9 (1979) 237-246.
11. D. Hegner, Age-dependence of molecular and functional changes in biological membrane properties. Mech. Ageing Dev., 14 (1980) 101-118.
12. G.S. Roth, J.J. Joseph and R.P. Mason, Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. T. I. N. S., 18 (1995) 203-206.
13. A. Bordoni, P.L. Biagi, E. Turchetto and S. Hrelia, Aging influence on delta-6-desaturase and fatty acid composition of rat liver microsomes. Biochem. Int., 17 (1988) 1001-1009.
14. J.M. Bourre and M. Piciotti, Delta-6-desaturation of alpha linolenic acid in brain and liver during development and aging. Neurosci. Lett., 141 (1992) 65-68.
15. J.M. Bourre, M. Piciotti and O. Dumont, D6 desaturase in brain and liver during development and aging. Lipids, 25 (1990) 354-356.
16. B. Fournier, J.A.M. Smeitink, L. Dordland, R. Berger, J.M. Saudubray and B.T. Poll-Thé, Peroxisomal disorders: a review. J. Inker. Metab. Dis., 17 (1994) 470-486.
17. M. Martinez, Abnormal profiles of polyunsaturated fatty acids in the brain, liver, kidney and retina of patients with peroxisomal disorders. Brain Res., 583 (1992) 171-182.
18. M. Martinez, M. Pineda, R. Vidai, J. Conill and B. Martin, Docosahexaenoic acid - A new therapeutic approach to peroxisomal-disorder patients: Experience with two cases. Neurology, 43 (1993) 1389-1397.
19. M. Neuringer, W.E. Connor, D.S. Lin, L. Brastad and S. Luck, Biochemical and functional effects of prenatal and postnatal ω3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc. Natl. Acad. Sci. USA, 83 (1986) 4021-5025.
20. A. Voss, M. Reinhart, S. Sankarappa and H. Sprecher, The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase. J. Biol. Chem., 266 (1991) 19995-20000.
21. R. Périchon and J.M. Bourre, Peroxisomal β-oxidation activity and catalase activity during development and aging in mouse liver. Biochimie, 77 (1995) 288-293.
22. LAω). J. Biol. Chem., 262 (1987) 801-810.
23. M.N. Milton, C.R. Elcombe and G.G. Gibson, On the mechanism of induction of microsomal cytochrome P450IVA1 and peroxisome proliferation in rat liver by clofibrate. Biochem. Pharmacol., 40 (1990) 2727-2732.
24. F. Bieri, V. Meier, W. Staubli, S.F. Muakkassah-Kelly, F. Waechter, P. Sagelsdorff and P. Bentley, Studies on the mechanism of induction of microsomal cytochrome P452 and peroxisomal bifunctional mRNAs by nafenopin in primary cultures of adult rat hepatocytes. Biochem. Pharmacol., 41 (1991) 310-312.
25. G.G. Gibson, E. Chinje, O. Sabzevari, P. Kentish and D.F.V Lewis, Peroxisomes: Biology and Importance in Toxicology and Medecine, Taylor and Francis, London, 1993, pp 119-136.
26. H. Aebi, Catalase. In H.U. Bergmeyer (ed.) Methods in Enzymatic Analysis, Vol. 2, Verlag Chemie-Academic Press, New York and London, 1974, pp 673-684.
27. H.R. Malher, Uricase. In H.U. Bergmeyer (ed.) Methods in Enzymatic Analysis, Vol. 1, Verlag Chemie-Academic Press, New York and London. 1974, pp 518.
28. R. Périchon, J.M. Bourre / Mechanisms of Ageing and Development 87 (1996) 115-126
29. P.B. Lazarow, Assay of peroxisomal β-oxidation of fatty acids. Methods in Enzymology, Vol. 72, Academic Press, New York (1981) pp 315-319.
30. R.J.A. Wanders, C.W.T. van Roermund, M.J.A. Wijland, R.B.H. Schutgens, A.W. Schram, H. van den Bosch and J.M. Tager, Studies on the peroxisomal oxidation of palmitate and lignocerate in rat liver. Biochim. Biophys. Acta, 919 (1987) 21-25.
31. T. Omura and R. Sato, The carbon monoxide-binding pigment of liver microsomes. Evidence for its haemoprotein nature. J. Biol. Chem., 239 (1964) 2370-2385.
32. K. Beier, A. Völkl and H.D. Fahimi, The impact of aging on enzyme proteins of rat liver peroxisomes: quantitative analysis by immunoblotting and immunoelectron microscopy. Virchows Archiv. B Cell Pathol., 63 (1993) 139-146.
33. T. Kyrklund and J. Meijer, Lipid composition of liver peroxisomes isolated from untreated and clofibrate-treated mice and rats. Comp. Biochem. Physiol., 109B (1994) 665-673.
34. F.R. Brown, A.J. McAdams, J.W. Cummins, R. Konkol, I. Singh, A.E. Moser and H.W. Moser, Cerebro-hepato-renal (Zellweger) syndrome and neonatal adrenoleukodystrophy: similarities in phenotype and accumulation of very long chain fatty acids. Johns Hopkins Med. J., 151 (1982) 344-361.
35. B.T. Poll-Thé, F. Roels, H. Ogier, H. Scotto, J. Vamecq, R.B.H. Schutgens, C.T.W, van Roermund, M.J.A van Wijland, A.W. Svhram, J.M. Tager and J.M. Saudubray, A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). Am. J. Hum. Genet., 42 (1988) 422-434.
36. J.M. Makowska, F.W. Bonner and G.G. Gibson, Species differences in ciprofibrate induction of hepatic cytochrome P4504A1 and peroxisome proliferation. J. Biochem. Toxicol., 7 (1992), 183-191.
37. R.A. Pegram, J.J. Diliberto, T.C. Moore, P. Gao and L.S. Birnbaum, 2,3,7,8-terachlorodibenzo-p-dioxin (TCDD) distribution and cytochrome P4501A induction in young adult and senescent male mice. Toxicol. Lett., 76 (1995) 119-126.
38. E.A. Lock, A.M. Mitchell and C.R. Elcombe, Biochemical mechanisms of induction of hepatic peroxisome proliferation. Ann. Rev. Pharmacol. Toxicol., 29 (1989) 145-163.
39. R. Sharma, B.G. Lake, J. Foster and G.G. Gibson, Microsomal cytochrome P452 induction and peroxisomal proliferation by hypolipidaemic agents in rat liver: a mechanistic inter-relationship. Biochem. Pharmacol., 37 (1988) 1193-1201.
40. P.R. Ortiz de Montellano, W.K. Chan, S.F. Tuck, R.M. Kaikaus, N.M. Bass and J.A. Peterson Mechanism-based probes of the topology and function of fatty acid hydroxylases. FASEB J., 6 (1992) 695-699.
41. S. Laganiere and B.P. Yu, Effect of chronic food restriction in aging rats I. Liver subcellular membranes. Mech. Ageing Dev., 48 (1989) 207-219.
42. R.A. Alvarez, G.R. Aguirre, G.M. Acland and R.E. Anderson, Docosapentaenoic acid is converted to docosahexaenoic acid in the retinas of normal and prcd-affected miniature poodle dog. Invest. Ophtahalmol. Vis. Sci., 35 (1994) 402-408.